$MXC
MEXCO ENERGY CORP

2024 Q3 Form 10-Q Financial Statement

#000149315224030787 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $1.749M $1.728M $1.748M
YoY Change 24.36% -1.18% -28.64%
Cost Of Revenue $437.4K $349.4K
YoY Change 25.19% -19.68%
Gross Profit $1.290M $1.399M
YoY Change -7.76% -30.57%
Gross Profit Margin 74.68% 80.02%
Selling, General & Admin $367.1K $341.0K
YoY Change 7.65% 7.04%
% of Gross Profit 28.44% 24.37%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $584.3K $539.7K $486.2K
YoY Change 52.88% 11.01% 25.59%
% of Gross Profit 41.82% 34.75%
Operating Expenses $1.340M $1.352M $1.184M
YoY Change 23.17% 14.19% 3.11%
Operating Profit $409.2K $376.0K $564.5K
YoY Change 28.41% -33.4% -56.64%
Interest Expense $21.67K $1.081K
YoY Change 1904.63% -65.47%
% of Operating Profit 5.76% 0.19%
Other Income/Expense, Net $19.76K $21.66K $22.61K
YoY Change -21.87% -4.21% -830.43%
Pretax Income $429.0K $397.6K $587.1K
YoY Change 24.71% -32.27% -54.79%
Income Tax $111.8K $106.6K $121.5K
% Of Pretax Income 26.05% 26.81% 20.69%
Net Earnings $317.2K $291.0K $465.6K
YoY Change 17.73% -37.49% -64.15%
Net Earnings / Revenue 18.13% 16.84% 26.63%
Basic Earnings Per Share $0.15 $0.14 $0.22
Diluted Earnings Per Share $0.15 $0.14 $0.21
COMMON SHARES
Basic Shares Outstanding 2.085M shares 2.090M shares 2.137M shares
Diluted Shares Outstanding 2.118M shares 2.135M shares 2.183M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.515M $3.376M
YoY Change -25.52% 528.77%
Cash & Equivalents $1.578M $2.515M $3.376M
Short-Term Investments
Other Short-Term Assets $74.51K $77.50K
YoY Change -3.86% 101.98%
Inventory
Prepaid Expenses $50.41K $51.45K $43.97K
Receivables $4.213K $9.955K $10.72K
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.568M $3.555M $4.358M
YoY Change -26.04% -18.42% 106.76%
LONG-TERM ASSETS
Property, Plant & Equipment $15.10M $14.33M $13.07M
YoY Change 9.52% 9.63% 8.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.300M $700.0K
YoY Change 85.71% 133.33%
Other Assets $6.448K $7.522K $11.83K
YoY Change -40.0% -36.39% -89.63%
Total Long-Term Assets $16.76M $15.80M $13.84M
YoY Change 13.63% 14.13% 10.09%
TOTAL ASSETS
Total Short-Term Assets $2.568M $3.555M $4.358M
Total Long-Term Assets $16.76M $15.80M $13.84M
Total Assets $19.33M $19.35M $18.20M
YoY Change 6.07% 6.34% 23.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $266.5K $210.3K
YoY Change 26.72% -25.93%
Accrued Expenses $48.71K $56.90K
YoY Change -14.39% 3.81%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $593.7K $516.4K $267.2K
YoY Change 162.17% 93.25% -21.12%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $799.5K $702.5K
YoY Change 13.81% -11.52%
Total Long-Term Liabilities $1.226M $1.186M $791.1K
YoY Change 44.7% 49.88% -0.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $593.7K $516.4K $267.2K
Total Long-Term Liabilities $1.226M $1.186M $791.1K
Total Liabilities $1.820M $1.702M $1.058M
YoY Change 69.48% 60.83% -6.56%
SHAREHOLDERS EQUITY
Retained Earnings $9.522M $9.205M $8.243M
YoY Change 11.85% 11.66% 78.15%
Common Stock $1.120M $1.120M $1.111M
YoY Change 0.78% 0.78% 0.25%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.879M $1.364M $590.5K
YoY Change 105.16% 131.02% 70.66%
Treasury Stock Shares
Shareholders Equity $17.51M $17.65M $17.14M
YoY Change
Total Liabilities & Shareholders Equity $19.33M $19.35M $18.20M
YoY Change 6.07% 6.34% 23.97%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income $317.2K $291.0K $465.6K
YoY Change 17.73% -37.49% -64.15%
Depreciation, Depletion And Amortization $584.3K $539.7K $486.2K
YoY Change 52.88% 11.01% 25.59%
Cash From Operating Activities $1.079M $1.616M
YoY Change -33.26% 8.06%
INVESTING ACTIVITIES
Capital Expenditures $517.4K $542.8K
YoY Change -4.69% -123.37%
Acquisitions
YoY Change
Other Investing Activities -$200.0K $278.8K
YoY Change -171.75% -4279.16%
Cash From Investing Activities -$717.4K -$264.1K
YoY Change 171.64% -88.66%
FINANCING ACTIVITIES
Cash Dividend Paid $209.0K $213.6K
YoY Change -2.15%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$320.0K -$211.4K
YoY Change 51.38%
NET CHANGE
Cash From Operating Activities $1.079M $1.616M
Cash From Investing Activities -$717.4K -$264.1K
Cash From Financing Activities -$320.0K -$211.4K
Net Change In Cash $41.23K $1.141M
YoY Change -96.39% -236.82%
FREE CASH FLOW
Cash From Operating Activities $1.079M $1.616M
Capital Expenditures $517.4K $542.8K
Free Cash Flow $561.2K $1.073M
YoY Change -47.71% -71.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
usd
CY2023Q2 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
usd
CY2024Q2 us-gaap Proceeds From Sale Of Oil And Gas Property And Equipment
ProceedsFromSaleOfOilAndGasPropertyAndEquipment
usd
CY2023Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
CY2024Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
pure
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
pure
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y
CY2023Q2 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2024Q2 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2024Q2 MXC Prepaid Drilling Current
PrepaidDrillingCurrent
23066 usd
CY2024Q1 MXC Prepaid Drilling Current
PrepaidDrillingCurrent
148748 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
51447 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
56193 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1727835 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1748419 usd
CY2024Q2 us-gaap Production Costs
ProductionCosts
437420 usd
CY2023Q2 us-gaap Production Costs
ProductionCosts
349407 usd
CY2024Q2 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
7711 usd
CY2023Q2 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
7356 usd
CY2024Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
539697 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
486186 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
367045 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
340969 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
1351873 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1183918 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
375962 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
564501 usd
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
22746 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
23695 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1083 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1081 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
21663 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22614 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
397625 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
587115 usd
CY2024Q2 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
31971 usd
CY2023Q2 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
32818 usd
CY2024Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
74615 usd
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
88683 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
106586 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
121501 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
291039 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
465614 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.22
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2090786 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2136165 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2135421 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2182800 shares
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
17628265 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
291039 usd
CY2024Q2 us-gaap Dividends
Dividends
209000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
77641 usd
CY2024Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
188637 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
52439 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
17651747 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
16832487 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
16832487 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
465614 usd
CY2023Q2 us-gaap Dividends
Dividends
213600 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2962 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
54975 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
17142438 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
17142438 usd
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2226916 shares
CY2024Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
12367 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2239283 shares
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
135517 shares
CY2024Q2 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
13766 shares
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
149283 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2090000 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
465614 usd
CY2024Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
74615 usd
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
88683 usd
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
52439 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
54975 usd
CY2024Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
539697 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
486186 usd
CY2024Q2 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
7711 usd
CY2023Q2 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
7356 usd
CY2024Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1075 usd
CY2023Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1081 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-45041 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-469846 usd
CY2024Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-4747 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-12528 usd
CY2024Q2 MXC Increase Decrease In Rightof Use Asset
IncreaseDecreaseInRightofUseAsset
143648 usd
CY2023Q2 MXC Increase Decrease In Rightof Use Asset
IncreaseDecreaseInRightofUseAsset
-13894 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
61874 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
32111 usd
CY2024Q2 us-gaap Increase Decrease In Asset Retirement Obligations
IncreaseDecreaseInAssetRetirementObligations
-11529 usd
CY2023Q2 us-gaap Increase Decrease In Asset Retirement Obligations
IncreaseDecreaseInAssetRetirementObligations
-2185 usd
CY2024Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
11905 usd
CY2024Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
143648 usd
CY2023Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-13894 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1078614 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1616195 usd
CY2024Q2 us-gaap Payments To Acquire Oil And Gas Property
PaymentsToAcquireOilAndGasProperty
517387 usd
CY2023Q2 us-gaap Payments To Acquire Oil And Gas Property
PaymentsToAcquireOilAndGasProperty
542840 usd
CY2024Q2 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
200000 usd
CY2023Q2 us-gaap Proceeds From Sale Of Oil And Gas Property And Equipment
ProceedsFromSaleOfOilAndGasPropertyAndEquipment
278749 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-717387 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-264091 usd
CY2024Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
77641 usd
CY2023Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2962 usd
CY2024Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
209000 usd
CY2023Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
213600 usd
CY2024Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
188637 usd
CY2023Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
750 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-319996 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-211388 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
41231 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1140716 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2473484 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2235771 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2514715 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3376487 usd
CY2024Q2 us-gaap Interest Paid Net
InterestPaidNet
9 usd
CY2024Q2 MXC Accrued Capital Expenditures Included In Accounts Payable
AccruedCapitalExpendituresIncludedInAccountsPayable
4727 usd
CY2023Q2 MXC Accrued Capital Expenditures Included In Accounts Payable
AccruedCapitalExpendituresIncludedInAccountsPayable
4487 usd
CY2024Q2 us-gaap Settlement Of Asset Retirement Obligations Through Noncash Payments Amount
SettlementOfAssetRetirementObligationsThroughNoncashPaymentsAmount
1130 usd
CY2023Q2 us-gaap Settlement Of Asset Retirement Obligations Through Noncash Payments Amount
SettlementOfAssetRetirementObligationsThroughNoncashPaymentsAmount
1080 usd
CY2024Q2 us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_801_eus-gaap--NatureOfOperations_zwWztFlj67Y3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_821_zraa5h6LEorf">Nature of Operations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mexco Energy Corporation (a Colorado corporation) and its wholly owned subsidiaries, Forman Energy Corporation (a New York corporation), Southwest Texas Disposal Corporation (a Texas corporation) and TBO Oil &amp; Gas, LLC (a Texas limited liability company) (collectively, the “Company”) are engaged in the acquisition, exploration, development and production of crude oil, natural gas, condensate and natural gas liquids (“NGLs”). Most of the Company’s oil and gas interests are centered in West Texas and Southeastern New Mexico; however, the Company owns producing properties and undeveloped acreage in fourteen states. All of Company’s oil and gas interests are operated by others.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_848_eus-gaap--UseOfEstimates_zeCzVDw8QCJe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zPDdfoN4u421">Estimates and Assumptions</span></b>. In preparing consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”), management is required to make informed judgments, estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements and affect the reported amounts of revenues and expenses during the reporting period. In addition, significant estimates are used in determining proved oil and gas reserves. Although management believes its estimates and assumptions are reasonable, actual results may differ materially from those estimates. The estimate of the Company’s oil and natural gas reserves, which is used to compute depreciation, depletion, amortization and impairment of oil and gas properties, is the most significant of the estimates and assumptions that affect these reported results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2 us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<p id="xdx_843_eus-gaap--ComparabilityOfPriorYearFinancialData_zY2nCVy0RjAh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_z3cJeeKhTz0g">Interim Financial Statements</span>. </b>In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments (consisting only of normal recurring accruals) necessary to present fairly the financial position of the Company as of June 30, 2024, and the results of its operations and cash flows for the interim periods ended June 30, 2024 and 2023. The consolidated financial statements as of June 30, 2024 and for the three-month periods ended June 30, 2024 and 2023 are unaudited. The consolidated balance sheet as of March 31, 2024 was derived from the audited balance sheet filed in the Company’s 2024 annual report on Form 10-K filed with the Securities and Exchange Commission (“SEC”). The results of operations for the periods presented are not necessarily indicative of the results to be expected for a full year. The accounting policies followed by the Company are set forth in more detail in Note 2 of the “Notes to Consolidated Financial Statements” in the Form 10-K. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted in this Form 10-Q pursuant to the rules and regulations of the SEC. However, the disclosures herein are adequate to make the information presented not misleading. It is suggested that these consolidated financial statements be read in conjunction with the consolidated financial statements and notes thereto included in the Form 10-K.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2024Q2 MXC Cost Method Investments Percentage Description
CostMethodInvestmentsPercentageDescription
The Company accounts for investments of less than 3% in limited liability companies at cost.
CY2024Q1 us-gaap Asset Retirement Obligation
AssetRetirementObligation
718808 usd
CY2024Q2 us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
1130 usd
CY2024Q2 us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
12375 usd
CY2024Q2 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
7711 usd
CY2024Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
715274 usd
CY2024Q2 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
30000 usd
CY2024Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
685274 usd
CY2024Q2 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
433373 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M13D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.73
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.565 pure
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0344 pure
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2024Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
12367 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
92316 usd
CY2024Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
77641 usd
CY2023Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
500 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2416 usd
CY2023Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2962 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1875 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2024Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
3.34
CY2024Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
18.05
CY2024Q2 us-gaap Area Of Land
AreaOfLand
4160 sqft
CY2024Q2 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
The lease does not include an option to renew and is a 36-month lease that was to expire in May 2021. In June 2020, in exchange for a reduction in rent for the months of June and July 2020, the Company agreed to a 2-month extension to its current lease agreement at the regular monthly rate extending its current lease expiration date to July 2021.
CY2021Q2 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
the Company agreed to extend its current lease at a flat (unescalated) rate for 36 months.
CY2024Q2 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
the Company agreed to extend its lease at a flat (unescalated) rate for another 36 months.
CY2024Q2 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2027-07-31
CY2024Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.09 pure
CY2024Q2 MXC Operating Lease Rightofuse Asset Gross
OperatingLeaseRightofuseAssetGross
19263 usd
CY2024Q2 MXC Operating Lease Amortization
OperatingLeaseAmortization
14425 usd
CY2024Q2 MXC Operating Lease Amendment
OperatingLeaseAmendment
158073 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
162911 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
48711 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
114200 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
162911 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
45066 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
60320 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
60320 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
20107 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
185813 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
22902 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
162911 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
48711 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
114200 usd
CY2024Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
10667 usd
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
10667 usd
CY2024Q2 us-gaap Sublease Income
SubleaseIncome
3893 usd
CY2023Q2 us-gaap Sublease Income
SubleaseIncome
3893 usd
CY2022Q3 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
IRA 2022, among other tax provisions, imposes a 15% corporate alternative minimum tax on corporations with book financial statement income in excess of $1.0 billion, effective for tax years beginning after December 31, 2022. The IRA 2022 also establishes a 1% excise tax on stock repurchases made by publicly traded U.S. corporations, effective for stock repurchases in excess of an annual limit of $1.0 million after December 31, 2022.
CY2024Q2 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
11905 usd
CY2024Q2 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
20066 usd
CY2023Q2 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
32818 usd
CY2024Q2 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
31971 usd
CY2023Q2 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
32818 usd
CY2024Q2 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
74615 usd
CY2023Q2 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
88683 usd
CY2024Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
74615 usd
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
88683 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
106586 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
121501 usd
CY2024Q2 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
86520 usd
CY2023Q2 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
88683 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
106586 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
121501 usd
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.268 pure
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.207 pure
CY2024Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
291039 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
465614 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2090786 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2136165 shares
CY2024Q2 us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
44635 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
46635 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2135421 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2182800 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.22
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
61125 shares
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Net Income Per Outstanding Unit Amount
AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount
15.34
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
63000 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Net Income Per Outstanding Unit Amount
AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount
15.32
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2022Q3 MXC Excise Tax Percentage
ExciseTaxPercentage
0.01 pure
CY2022Q3 MXC Excise Tax Description On Stock Repurchases
ExciseTaxDescriptionOnStockRepurchases
, effective for stock repurchases in excess of an annual limit of $1,000,000 after December 31, 2022
CY2024Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
13766 shares
CY2024Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
188637 usd
CY2024Q2 us-gaap Share Price
SharePrice
13.70
CY2023Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2024Q2 us-gaap Dividends
Dividends
209000 usd
CY2023Q2 us-gaap Dividends
Dividends
213600 usd

Files In Submission

Name View Source Status
0001493152-24-030787-index-headers.html Edgar Link pending
0001493152-24-030787-index.html Edgar Link pending
0001493152-24-030787.txt Edgar Link pending
0001493152-24-030787-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
mxc-20240630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mxc-20240630_def.xml Edgar Link unprocessable
mxc-20240630_lab.xml Edgar Link unprocessable
mxc-20240630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
mxc-20240630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable